Article by Rūta PumArticle by Rūta Pumputienė “Changes in medicine pricing fosters hope for more transparency and innovation”putienė “Changes in medicine pricing fosters hope for more transparency and innovation”

“Pharmaceutical innovators are facing many obstacles in Lithuania, which need to be addressed by the Ministry of Health and the Government.”

“First, the decision making process for including innovative medicines in the Reimbursable Medicines Pricelist has to be improved and shortened. Although the Law on Pharmaceutical Activities has determined a 180-day period for adopting these decisions, in reality it often fails to comply with this, leaving Lithuania dragging far behind Europe’s more advanced reimbursement technologies,” said R. Pumputienė.

Read more at: http://www.amcham.lt/2017/06/12/Rūta-pumputiene-changes-in-medicine-pricing-fosters-hope-for-more-transparency-and-innovation/

arpk-admin